The US Food and Drug Administration plans to add two more product areas to its ongoing Total Product Life Cycle Advisory Program (TAP), the agency announced on 1 July.
The expansion will add devices reviewed by the Office of Radiological Health and the Division of Ophthalmic Devices in fall...